Easton Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Easton Pharmaceutica
EAPH Stock  USD 0.00001  0.00  0.00%   
Easton Pharmaceutica's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Easton Pharmaceutica's valuation are provided below:
Gross Profit
201.4 K
Market Capitalization
13.4 K
Enterprise Value Revenue
5.6431
Revenue
1.6 M
Revenue Per Share
0.001
We have found one hundred twenty available fundamental signals for Easton Pharmaceutica, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Easton Pharmaceutica prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 690 K. The Easton Pharmaceutica's current Enterprise Value is estimated to increase to about (25.3 B)

Easton Pharmaceutica Total Revenue

1.56 Million

Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.11. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
  
Build AI portfolio with Easton Stock
Check out the analysis of Easton Pharmaceutica Correlation against competitors.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.

Easton Pharmaceutica Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.3 M11.7 M6.7 M
Slightly volatile
Total Current Liabilities557.7 K558.7 K645.7 K
Pretty Stable
Other Liabilities250.1 K162.1 K193.2 K
Pretty Stable
Accounts Payable327.4 K230.2 K263.9 K
Pretty Stable
Short Term Investments285.6 K321.3 K350.7 K
Slightly volatile
Other Current Assets514.8 K490.2 K251.8 K
Slightly volatile
Total Liabilities2 M3.8 M2.6 M
Slightly volatile
Intangible Assets6 M9.1 M13.6 M
Slightly volatile
Common Stock162.4 K154.7 K97 K
Slightly volatile
Property Plant Equipment11 M8 M15.5 M
Slightly volatile
Other Current Liabilities52.4455.218.9 M
Slightly volatile
Total Stockholder Equity8.3 M7.9 M4 M
Slightly volatile
Other Assets80.4 K84.6 K450.1 K
Slightly volatile
Long Term Debt1.9 M2.9 M1.8 M
Slightly volatile
Short and Long Term Debt52.4455.244.2 K
Slightly volatile
Total Current Assets234 K383.7 K309.2 K
Slightly volatile
Short Term Debt259.6 K247.2 K162.5 K
Slightly volatile
Net Receivables184.7 K175.9 K101.1 K
Slightly volatile
Good Will110.3 M124.1 M135.5 M
Slightly volatile
Deferred Long Term Liabilities11.1 M12.8 M9.6 M
Slightly volatile
Long Term Investments1.5 M1.6 M356.3 M
Slightly volatile
Net Debt4.7 M2.9 M2.8 M
Slightly volatile
Non Current Assets Total9.8 M8.8 M10.3 M
Very volatile
Common Stock Shares Outstanding1.1 B1.2 B1.3 B
Slightly volatile
Non Current Liabilities Total5 M3.1 M2.9 M
Slightly volatile
Net Invested Capital12.6 M10.8 M10 M
Slightly volatile
Capital Stock143 K154.7 K129.1 K
Slightly volatile

Easton Pharmaceutica Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative161.2 K169.7 K331.8 K
Slightly volatile
Research Development179.8 K120.3 K136.1 K
Very volatile
Discontinued Operations966.1 K1 M3.3 M
Slightly volatile
Non Recurring93.4 M102.1 M113.4 M
Slightly volatile
Minority Interest308.7 K324.9 K2.8 M
Slightly volatile

Easton Pharmaceutica Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities54.7257.6328.4 K
Slightly volatile
Change To Inventory48.4 K48.3 K41.6 K
Slightly volatile
Depreciation16.1 M16 M19 M
Slightly volatile
Dividends Paid9.5 M9.5 M7.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.940.991.8 K
Slightly volatile
Days Sales Outstanding59.2858.0451.6468
Slightly volatile
Average Payables386.6 K205.9 K219.7 K
Pretty Stable
Capex To Depreciation0.02430.02550.2649
Slightly volatile
EV To Sales6.717.061.8 K
Slightly volatile
Inventory Turnover8.327.928.2073
Slightly volatile
Days Of Inventory On Hand45.2947.671.2 K
Slightly volatile
Payables Turnover1.511.441.2067
Slightly volatile
Sales General And Administrative To Revenue0.360.381.7493
Slightly volatile
Average Inventory314.2 K415.5 K442.2 K
Pretty Stable
Research And Ddevelopement To Revenue4.612.372.2052
Slightly volatile
Capex To Revenue0.01320.01390.0336
Slightly volatile
Cash Per Share16.2915.526.9429
Slightly volatile
Days Payables Outstanding2492622.2 K
Slightly volatile
Intangibles To Total Assets0.460.70.7428
Slightly volatile
Current Ratio0.80.620.9273
Pretty Stable
Receivables Turnover10.386.517.3462
Slightly volatile
Capex Per Share0.00.00.0013
Slightly volatile
Average Receivables201.4 K191.8 K199.3 K
Slightly volatile
Revenue Per Share0.00130.00130.004
Slightly volatile
Interest Debt Per Share0.0020.00210.0041
Slightly volatile
Debt To Assets0.240.220.2563
Very volatile
Graham Number4.0E-45.0E-45.0E-4
Slightly volatile
Operating Cycle10010691.0117
Slightly volatile
Days Of Payables Outstanding2492622.2 K
Slightly volatile
Long Term Debt To Capitalization0.270.240.3189
Pretty Stable
Total Debt To Capitalization0.290.30.4934
Slightly volatile
Quick Ratio0.670.620.8732
Pretty Stable
Net Income Per E B T0.00110.00120.0611
Slightly volatile
Cash Ratio35.3 K33.6 K15 K
Slightly volatile
Days Of Inventory Outstanding45.2947.671.2 K
Slightly volatile
Days Of Sales Outstanding59.2858.0451.6468
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.261.0373
Slightly volatile
Fixed Asset Turnover0.240.260.3586
Slightly volatile
Debt Ratio0.240.220.2563
Very volatile
Price Sales Ratio0.940.991.8 K
Slightly volatile
Asset Turnover0.130.10.0893
Pretty Stable
Gross Profit Margin0.140.150.256
Slightly volatile

Easton Pharmaceutica Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap690 K726.3 K4.8 M
Pretty Stable

About Easton Pharmaceutica Financial Statements

Investors use fundamental indicators, such as Easton Pharmaceutica's revenue or net income, to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 0.38  0.36 
Research And Ddevelopement To Revenue 2.37  4.61 
Capex To Revenue 0.01  0.01 
Ebit Per Revenue(0.19)(0.20)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:
How To Invest In Easton
Details
Is Easton Stock a good investment?
Details
What is Easton Pharmaceutica's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Easton Pharmaceutica Correlation against competitors.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Return On Assets
(0.01)
Return On Equity
(0.03)
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY